Company Filing History:
1 out of 314 
1 out of 1 Years Active: 2023
Title: Giovanni Scambia: Innovator in Cancer Treatment
Introduction
Giovanni Scambia is a notable inventor based in Campobasso, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic agents.
Latest Patents
Scambia holds a patent for "NEK6 kinase inhibitors useful for the treatment of solid tumors." This invention focuses on mitotic kinases that regulate centrosome dynamics and the functions of the mitotic spindle, which are potential targets for antitumor therapy. The patent identifies molecules with inhibitory activity on NEK6 and describes their use in compositions for treating tumors, both as monotherapy and in combination with other drugs.
Career Highlights
Throughout his career, Giovanni Scambia has worked with esteemed organizations such as the National Research Council of Italy (Consiglio Nazionale Delle Ricerche) and Molipharma S.r.l. His work has been pivotal in advancing cancer treatment methodologies.
Collaborations
Scambia has collaborated with notable colleagues, including Maria Cristina De Rosa and Davide Pirolli, contributing to the advancement of research in his field.
Conclusion
Giovanni Scambia's innovative work in developing NEK6 kinase inhibitors showcases his commitment to improving cancer treatment options. His contributions continue to influence the medical research landscape.